Cemiplimab plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer with PD-L1≥1%: 5‑year update of EMPOWER-Lung 3 results

P Hoffknecht, M Gogishvili, T Makharadze, T Melkadze, D Giorgadze, K Penkov, K Laktionov, E Kalinka, G Nemsadze, M Nechaeva, I Rozhkova, DA G McIntyre, X Jia, M Kaul, S Chua, K Gillis, F Seebach, H Magnan, E Kim, A Baramidze · Pneumologie · 2026 · Heft S 01 S 01 · S. S59-S60